Evidence map›Paper›PMID 28863191›Full record

ArticlePloS one2017

Anti-cancer stem cell activity of a sesquiterpene lactone isolated from Ambrosia arborescens and of a synthetic derivative.

Wendy Soria Sotillo, Rodrigo Villagomez, Sandra Smiljanic, Xiaoli Huang, Atena Malakpour, Sebastian Kempengren, Gloria Rodrigo, Giovanna Almanza, Olov Sterner, Stina Oredsson

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Effect ofVeterinary world · 2024
    Article
  7. Article
  8. Article
  9. Review
  10. Poorly Investigated Ecuadorian Medicinal Plants.Plants (Basel, Switzerland) · 2022
    Review
  11. Acute toxicity of aqueous extract ofToxicological research · 2022
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Suppressive role of Viola odorata extract on malignant characters of mammosphere-derived breast cancer stem cells.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Wendy Soria SotilloDepartment of Biology, Lund University, Lund, Sweden.
Rodrigo VillagomezCentre for Analysis and Synthesis, Department of Chemistry, Lund University, Lund, Sweden.
Sandra SmiljanicDepartment of Biology, Lund University, Lund, Sweden.
Xiaoli HuangDepartment of Biology, Lund University, Lund, Sweden.
Atena MalakpourDepartment of Biology, Lund University, Lund, Sweden.
Sebastian KempengrenDepartment of Biology, Lund University, Lund, Sweden.
Gloria RodrigoMolecular Biology and Biotechnology Institute, University Major of San Andrés, La Paz, Bolivia.
Giovanna AlmanzaChemical Research Institute, University Major of San Andres, La Paz, Bolivia.
Olov SternerCentre for Analysis and Synthesis, Department of Chemistry, Lund University, Lund, Sweden.
Stina OredssonDepartment of Biology, Lund University, Lund, Sweden.ORCID http://orcid.org/0000-0003-2529-7106
Lund University · SEUniversidad Mayor de San Andrés · BO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

New regimens are constantly being pursued in cancer treatment, especially in the context of treatment-resistant cancer stem cells (CSCs) that are assumed to be involved in cancer recurrence. Here, we investigated the anti-cancer activity of sesquiterpene lactones (SLs) isolated from Ambrosia arborescens and of synthetic derivatives in breast cancer cell lines, with a specific focus on activity against CSCs. The breast cancer cell lines MCF-7, JIMT-1, and HCC1937 and the normal-like breast epithelial cell line MCF-10A were treated with the SLs damsin and coronopilin, isolated from A. arborescens, and with ambrosin and dindol-01, synthesized using damsin. Inhibitory concentration 50 (IC50) values were obtained from dose-response curves. Based on IC50 values, doses in the μM range were used for investigating effects on cell proliferation, cell cycle phase distribution, cell death, micronuclei formation, and cell migration. Western blot analysis was used to investigate proteins involved in cell cycle regulation as well as in the NF-κB pathway since SLs have been shown to inhibit this transcription factor. Specific CSC effects were investigated using three CSC assays. All compounds inhibited cell proliferation; however, damsin and ambrosin were toxic at single-digit micromolar ranges, while higher concentrations were required for coronopilin and dindol-01. Of the four cell lines, the compounds had the least effect on the normal-like MCF-10A cells. The inhibition of cell proliferation can partly be explained by downregulation of cyclin-dependent kinase 2. All compounds inhibited tumour necrosis factor-α-induced translocation of NF-κB from the cytoplasm to the nucleus. Damsin and ambrosin treatment increased the number of micronuclei; moreover, another sign of DNA damage was the increased level of p53. Treatment with damsin and ambrosin decreased the CSC subpopulation and inhibited cell migration. Our results suggest that these compounds should be further investigated to find efficient CSC-inhibiting compounds.

Indexed as

AmbrosiaAntineoplastic AgentsAzulenesCell CycleCell Line, TumorCell NucleusCell ProliferationCytoplasmDose-Response Relationship, DrugHumansInhibitory Concentration 50LactonesMCF-7 CellsMicronucleus TestsNeoplastic Stem CellsNF-kappa BambrosinAntineoplastic AgentsAzulenesdamsinLactonesNF-kappa BPlant ExtractsSesquiterpenesSesquiterpenes, GuaianeTumor Necrosis Factor-alpha

Identifiers

PMID28863191
PMCPMC5581169
OpenAlexW2753858323

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.